An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
暂无分享,去创建一个
A. Nisalak | D. Vaughn | B. Innis | B. Raengsakulrach | K. Myint | M. Gettayacamin | C. Hoke | G. D. Young | L. Ferguson | V. Thirawuth
[1] D. Vaughn,et al. Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus. , 1999, The American journal of tropical medicine and hygiene.
[2] A. Nisalak,et al. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys. , 1999, The American journal of tropical medicine and hygiene.
[3] P. Nuttall. Kass handbook of infectious diseases: Exotic viral infections: J. S. Porterfield (editor). Chapman & Hall Medical, 1995. xiv+385 pp. Price £85.00. ISBN 0-412-63030-3 , 1997 .
[4] P. Arlien‐Søborg,et al. Neurological complications and Japanese encephalitis vaccination , 1996, The Lancet.
[5] T. Matsuishi,et al. Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains). , 1995, Journal of neurology, neurosurgery, and psychiatry.
[6] E. Paoletti,et al. Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. , 1994, Vaccine.
[7] N. Begg,et al. Systemic allergic reactions to Japanese encephalitis vaccines. , 1994, Vaccine.
[8] E. Paoletti,et al. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. , 1992, Virology.
[9] D. Vaughn,et al. The epidemiology of Japanese encephalitis: prospects for prevention. , 1992, Epidemiologic reviews.
[10] T. Ruff,et al. Adverse reactions to Japanese encephalitis vaccine , 1991, The Lancet.
[11] H. Robinson,et al. Japanese encephalitis vaccine and adverse effects among travellers. , 1991, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.
[12] T. Rønne,et al. Side-effects with Japanese encephalitis vaccine , 1991, The Lancet.
[13] E. Paoletti,et al. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. , 1991, Virology.
[14] S. Chelliah,et al. Protective effect of 6-MFA, a fungal interferon inducer against Japanese encephalitis virus in bonnet macaques. , 1990, The Indian journal of medical research.
[15] T. Sata,et al. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus , 1990, Journal of virology.
[16] W. Ma,et al. Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies , 1989, Journal of medical virology.
[17] A. Nisalak,et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.
[18] D. Trent,et al. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. , 1988, Vaccine.
[19] A. Nisalak,et al. Protection against Japanese encephalitis by inactivated vaccines. , 1988, The New England journal of medicine.
[20] Y. Xin,et al. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. , 1988, The American journal of tropical medicine and hygiene.
[21] U. Chaturvedi,et al. Japanese encephalitis--an important cause of acute childhood encephalopathy in Lucknow, India. , 1988, Postgraduate medical journal.
[22] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[23] A. Nisalak,et al. Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line. , 1986, The American journal of tropical medicine and hygiene.
[24] 難病医学研究財団,et al. Virus vaccines in Asian countries , 1986 .
[25] G. Kuno,et al. Antigen capture ELISA for the identification of dengue viruses. , 1985, Journal of virological methods.
[26] M. Elwell,et al. Intranasal infection of monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly (I).poly (C). , 1977, The American journal of tropical medicine and hygiene.
[27] A. Budak. [Japanese encephalitis]. , 1975, Fel'dsher i akusherka.
[28] T. Miura. A new method for a potency test of Japanese encephalitis vaccine. Direct challenge method on suckling mice by subcutaneous inoculation. , 1970, Bulletin of the World Health Organization.
[29] A. Nisalak,et al. A plaque reduction test for dengue virus neutralizing antibodies. , 1967, Journal of immunology.
[30] J. Grayston,et al. Protective Studies in Mice and Monkeys with an Inactivated Japanese Encephalitis Virus Vaccine Grown in Hamster Diploid Cell Culture.∗ , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[31] W. Scherer,et al. The anamnestic antibody response to Japanese encephalitis virus in monkeys and its implications concerning naturally acquired immunity in man. , 1961, Journal of immunology.
[32] J. Casals,et al. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. , 1958, The American journal of tropical medicine and hygiene.
[33] I. Imam,et al. Challenge of monkeys with Japanese B virus after immunization by West Nile infection plus Japanese B vaccine. , 1957, Journal of immunology.